псилоцибин 和 其他 经典 迷幻 药物 在 抑郁症
D J Nutt1, J M Peill2, B Weiss2
1Centres for Neuropsychopharmacology & Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK. d.nutt@imperial.ac.uk.
Current topics in behavioral neurosciences
|November 13, 2023
概括
像 псилоцибин这样的迷幻化合物,通过诱导深刻的心理体验和改变大脑活动,显示出对治疗抑郁症的希望. 这些效果,当与治疗相结合时,提供快速和持续的情绪改善,与传统抗抑郁药不同.
科学领域:
- 神经科学是一个神经科学.
- 心理药理学 心理药理学
- 临床心理学 临床心理学
背景情况:
- 迷幻药物正在临床研究中重新出现,用于治疗各种疾病,特别是抑郁症.
- 针对5-HT2A受体的特定迷幻药物,如 псилоцибин和DMT,诱导独特的心理效应.
研究的目的:
- 总结关于在抑郁症患者中使用迷幻药的科学研究.
- 突出临床,心理和神经成像特征,有助于治疗效果.
主要方法:
- 关于抑郁症心理干预的科学文献的综述.
- 从研究中分析临床,心理和神经成像数据.
主要成果:
- 迷幻药与心理支持相结合,在抑郁症中产生快速,持久的情绪改善.
- 治疗效应可能源于增加的大脑,增强认知灵活性和改变自我参考处理.
结论:
- 血清色精神药物为抑郁症提供了一种新的治疗途径.
- 迷幻药的大脑机制可能与传统抗抑郁药不同.
相关概念视频
Hallucinogens and Psychedelics
179
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
179
Antidepressant Drugs: MAOIs and Other Agents
252
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
252
CNS Stimulants: Psychedelic Agents
158
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
158
Depressive Disorders: Etiology
104
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
104
Cognitive Therapy
154
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
154
Electroconvulsive Therapy
47
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
47


